The goal of this study was to explore the efficacy and safety of neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy in patients with locally advanced esophageal squamous cell carcinoma
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
70
Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy
Anhui provincial hospital
Hefei, China
RECRUITINGpCR
Pathologic Complete Response
Time frame: immediately after the intervention/procedure/surgery
R0 resection rate
R0 resection rate
Time frame: immediately after the intervention/procedure/surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.